Federico Grossi
Director/Board Member presso Endoprotech, Inc.
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
Federico Grossi occupa la posizione di Chief Medical Officer per Apellis Pharmaceuticals, Inc. È anche nel consiglio di amministrazione di Endoprotech, Inc. In passato il Dr. Grossi è stato direttore della ricerca clinica presso Potentia Pharmaceuticals, Inc., vicepresidente esecutivo per Potentia Pharmaceuticals, Inc. e membro del team di trapianti all'Università di Louisville. Ha conseguito una laurea e un dottorato presso l'Università di Louisville e un dottorato presso l'Università Nazionale di Cordoba.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 05/01/2023 | 94 884 ( 0.08% ) | 6 M $ | 31/03/2024 |
Posizioni attive di Federico Grossi
| Società | Posizione | Inizio |
|---|---|---|
Endoprotech, Inc.
 Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Director/Board Member | - |
Precedenti posizioni note di Federico Grossi
| Società | Posizione | Fine |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03/01/2023 |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Corporate Officer/Principal | 01/09/2014 |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Chief Tech/Sci/R&D Officer | 01/04/2010 |
| University of Louisville | Corporate Officer/Principal | - |
Formazione di Federico Grossi
| University of Louisville | Doctorate Degree |
| National University of Cordoba | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Endoprotech, Inc.
Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Distribution Services |
- Borsa valori
- Insiders
- Federico Grossi
